Delivery Order SPE2DB20D1100-SPE2DB24FA7E7
Award Date
3/13/24
Potential Completion Date
4/3/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,504.62 firm-fixed-price contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tecentriq 840 mg/14 ml vials. The contract award, valued at $12,024.45, was made by the Defense Logistics Agency (DLA) on October 16, 2024, with a completion date of November 6, 2024. This is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $21,261.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $16,032.60 firm fixed-price delivery order is for the supply of 840 mg/14 ml vials of the drug Tecentriq. The contract has an ultimate completion date of August 21, 2024 and was awarded on July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,368.91 order is for the supply of TECENTRIQ 1,200 MG/20 ML VIAL 20ML, a branded oncology medication, to support the recurring medical needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. This is a firm-fixed-price delivery order contract with a completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $26,019.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "TECVAYLI 153 MG/1.7 ML VIAL 1.7ML" and has a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,804.16, is for the delivery of ACTEMRA 80 MG/4 ML VIAL 4ML, a specialty pharmaceutical product. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through January 16, 2025. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $65,688.70, is for the supply of 4554809505 - TECENTRIQ 1,200 MG/20 ML VIAL 20ML. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,420.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...